Skip to content
10-Q

Quarterly Report

REGEN BIOPHARMA, INC. RGBP RGBPP

0001493152-26-022924

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · May 1, 2026 511.96M sh
Shares Diluted Q2 2026 · Mar 31, 2026 184.94M sh
Shares Diluted Q2 2026 · Mar 31, 2026 141.62M sh
Shares Diluted Q2 2026 · Mar 31, 2025 21.55M sh
Shares Diluted Q2 2026 · Mar 31, 2025 18.73M sh
Operating Cash Flow Q2 2026 · Mar 31, 2026 −$261.18K
Operating Cash Flow Q2 2026 · Mar 31, 2025 −$167.61K
Cash And Equivalents Q2 2026 · Mar 31, 2026 $271
Cash And Equivalents Q2 2026 · Sep 30, 2025 $69.56K
Stockholders Equity Q2 2026 · Mar 31, 2026 −$5.36M
Stockholders Equity Q2 2026 · Dec 31, 2025 −$6.57M
Stockholders Equity Q2 2026 · Sep 30, 2025 −$6.28M
Stockholders Equity Q2 2026 · Mar 31, 2025 −$5.7M
Stockholders Equity Q2 2026 · Dec 31, 2024 −$5.68M
Stockholders Equity Q2 2026 · Sep 30, 2024 −$5.22M
Current Liabilities Q2 2026 · Mar 31, 2026 $5.62M
Current Liabilities Q2 2026 · Sep 30, 2025 $6.56M
Total Liabilities Q2 2026 · Mar 31, 2026 $5.62M
Total Liabilities Q2 2026 · Sep 30, 2025 $6.56M
Current Assets Q2 2026 · Mar 31, 2026 $260.19K
Current Assets Q2 2026 · Sep 30, 2025 $274.63K
Total Assets Q2 2026 · Mar 31, 2026 $260.19K
Total Assets Q2 2026 · Sep 30, 2025 $274.63K
Eps Diluted Q2 2026 · Mar 31, 2026 $0.00
Eps Diluted Q2 2026 · Mar 31, 2026 $0.00
Eps Diluted Q2 2026 · Mar 31, 2025 $0.00
Eps Diluted Q2 2026 · Mar 31, 2025 −$0.03
Eps Basic Q2 2026 · Mar 31, 2026 $0.00
Eps Basic Q2 2026 · Mar 31, 2026 $0.00
Eps Basic Q2 2026 · Mar 31, 2025 $0.00
Eps Basic Q2 2026 · Mar 31, 2025 −$0.03
Rd Expense Q2 2026 · Mar 31, 2026 $2.22K
Rd Expense Q2 2026 · Mar 31, 2026 $212.22K
Rd Expense Q2 2026 · Mar 31, 2025 $0
Rd Expense Q2 2026 · Mar 31, 2025 $0
Net Income Q2 2026 · Mar 31, 2026 $991.93K
Net Income Q2 2026 · Mar 31, 2026 $24.07K
Net Income Q2 2026 · Sep 30, 2025 −$1.27M
Net Income Q2 2026 · Mar 31, 2025 −$19.35K
Net Income Q2 2026 · Mar 31, 2025 −$534.74K
Operating Income Q2 2026 · Mar 31, 2026 −$153.71K
Operating Income Q2 2026 · Mar 31, 2026 −$705.33K
Operating Income Q2 2026 · Mar 31, 2025 −$113.35K
Operating Income Q2 2026 · Mar 31, 2025 −$174.73K
Revenue Q2 2026 · Mar 31, 2026 $59.07K
Revenue Q2 2026 · Mar 31, 2026 $118.13K
Revenue Q2 2026 · Mar 31, 2025 $59.07K
Revenue Q2 2026 · Mar 31, 2025 $118.13K